Join
Live feed
·
INSIDERFilingvia Quantisnow
Cue Biopharma Inc. logo

VP, Prin. Accounting Officer Meluzio Michael Vincent converted options into 13,647 shares and sold $169,324 worth of shares (5,628 units at $30.09), increasing direct ownership by 20% to 48,961 units (SEC Form 4) (tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CUE (Cue Biopharma Inc.) and more on Quantisnow.